logo

For the Inventor, By the Inventor

La Jolla, CA, United States of America

Wylie Walker Vale, Jr

This inventor holds 17 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Research Development Foundation, The Salk Institute. Active years: 1998-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wylie Walker Vale, Jr. Retrieved from https://idiyas.com/inventor/wylie-walker-vale-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 47.1



Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 68(Granted Patents)


Company Filing History:

goldMedal15 out of 299 
 
Research Development Foundation
 patents
silverMedal2 out of 593 
 
The Salk Institute
 patents

Years Active: 1998-2017

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents
1. 9555032 - Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating CRF receptor signaling (2017-01-31),
2. 9546210 - Cripto antagonism of activin and TGF-b signaling (2017-01-17),
3. 8258279 - Isolated nucleic acids encoding soluble corticotropin releasing factor receptor type 2 (sCRFR2) polypeptides (2012-09-04),
4. 7820620 - Cripto antagonism of activin and TGF-b signaling (2010-10-26),
5. 7815905 - Methods of increasing insulin sensitivity or decreasing insulin secretion by administering corticotropin releasing factor receptor-2 inhibitors (2010-10-19),
6. 7674463 - Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist (2010-03-09),
7. 7638607 - Urocortin proteins and uses thereof (2009-12-29),
8. 7575751 - Activin-A mutants (2009-08-18),
9. 7507794 - Isolated soluble corticotropin releasing factor receptor type 2 (sCRFR2) (2009-03-24),
10. 7488865 - Urocortin-deficient mice and uses thereof (2009-02-10),
11. 7455839 - Method of inhibiting the formation of inhibin/betaglycan complexes with an anti-betaglycan antibody (2008-11-25),
12. 7223846 - Urocortin proteins and uses thereof (2007-05-29),
13. 7141546 - CRFR2 selective ligands (2006-11-28),
14. 6692744 - Betaglycan as an inhibin receptor and uses thereof (2004-02-17),
15. 6353152 - Corticotropin releasing factor receptor 2 deficient mice and uses thereof (2002-03-05),

Title: The Innovative Journey of Wylie Walker Vale, Jr.

Introduction:

Wylie Walker Vale, Jr. is a visionary inventor based in La Jolla, California. His passion for creating groundbreaking solutions has led to numerous patents and innovations in various industries.

Latest Patents:

Wylie Walker Vale, Jr. holds several recent patents in the fields of renewable energy technology, medical devices, and sustainable agriculture. His commitment to pushing the boundaries of innovation is evident in his latest inventions.

Career Highlights:

Throughout his illustrious career, Wylie Walker Vale, Jr. has been recognized for his contributions to the world of technology and science. His innovative spirit has driven him to develop cutting-edge solutions that have the potential to revolutionize the way we live and work.

Collaborations:

Wylie Walker Vale, Jr. has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work with diverse teams and experts has been instrumental in the success of his projects.

Conclusion:

In conclusion, Wylie Walker Vale, Jr. stands as a beacon of innovation in the inventor community. His relentless pursuit of excellence and his dedication to creating a better future through his inventions make him a true pioneer in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…